Q4 2022 Holdings
Filed 2023-02-14 | 90 holdings | $349.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prometheus Bioscience, Inc.Put | LONG OPTION PUTS | 74349U108 | $19.0M | 172,400 | 5.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | EQUITIES | 558868105 | $14.5M | 49,898 | 4.1% |
| Bellus Health Inc(BLU) | EQUITIES | 07987C204 | $14.0M | 1,707,370 | 4.0% |
| Poseida Therapeutics Inc(PSTXUSD) | EQUITIES | 73730P108 | $11.8M | 2,230,000 | 3.4% |
| Viewray Inc(VRAYQ) | EQUITIES | 92672L107 | $10.8M | 2,405,360 | 3.1% |
| Xenon Pharmaceuticals Inc(XENE) | EQUITIES | 98420N105 | $10.0M | 253,655 | 2.9% |
| Akero Therapeutics Inc(AKRO) | EQUITIES | 00973Y108 | $9.4M | 172,100 | 2.7% |
| Anavex Life Science Corp(AVXL)Put | LONG OPTION PUTS | 032797300 | $9.3M | 1,007,700 | 2.7% |
| Immunovant Inc(IMVT) | EQUITIES | 45258J102 | $9.2M | 519,614 | 2.6% |
| Nuvalent Inc(NUVL) | EQUITIES | 670703107 | $9.0M | 302,963 | 2.6% |
| Morphic Holding Inc | EQUITIES | 61775R105 | $8.9M | 334,535 | 2.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | EQUITIES | 02043Q107 | $8.9M | 37,652 | 2.6% |
| Madrigal Parmaceuticals, Inc.(MDGL)Put | LONG OPTION PUTS | 558868105 | $8.7M | 30,000 | 2.5% |
| Akero Therapeutics Inc(AKRO)Put | LONG OPTION PUTS | 00973Y108 | $8.2M | 150,000 | 2.4% |
| Akero Therapeutics Inc(AKRO)Call | LONG OPTION CALLS | 00973Y108 | $8.2M | 150,000 | 2.4% |
| Intra-Cellular Therapies Inc(ITCIEUR) | EQUITIES | 46116X101 | $7.4M | 140,366 | 2.1% |
| Oric Pharmaceuticals Inc(ORIC) | EQUITIES | 68622P109 | $7.3M | 1,236,296 | 2.1% |
| Terns Pharmaceuticals Inc(TERN) | EQUITIES | 880881107 | $7.1M | 700,000 | 2.0% |
| Mersana Therapeutics Inc | EQUITIES | 59045L106 | $6.7M | 1,140,182 | 1.9% |
| Biogen Idec Inc(BIIB) | EQUITIES | 09062X103 | $6.1M | 21,975 | 1.7% |
| Cerus Corp(CERS) | EQUITIES | 157085101 | $6.0M | 1,634,014 | 1.7% |
| Cvrx Inc(CVRX) | EQUITIES | 126638105 | $5.8M | 314,584 | 1.7% |
| Aclaris Therapeutics Inc(ACRS) | EQUITIES | 00461U105 | $5.5M | 352,193 | 1.6% |
| Prometheus Biosciences Inc | EQUITIES | 74349U108 | $5.5M | 50,000 | 1.6% |
| Cincor Pharma Inc | EQUITIES | 17240Y109 | $4.9M | 395,382 | 1.4% |
| GlaxoSmithKline PLC(GSK) | EQUITIES | 37733W204 | $4.8M | 136,178 | 1.4% |
| Veracyte Inc(VCYT) | EQUITIES | 92337F107 | $4.7M | 200,000 | 1.4% |
| Krystal Biotech Inc(KRYS) | EQUITIES | 501147102 | $4.6M | 58,535 | 1.3% |
| Bioatla Inc(BCAB) | EQUITIES | 09077B104 | $4.5M | 546,875 | 1.3% |
| United Therapeutics Corp(UTHR) | EQUITIES | 91307C102 | $4.5M | 16,048 | 1.3% |
| Gilead Sciences Inc(GILD) | EQUITIES | 375558103 | $4.5M | 51,962 | 1.3% |
| Prothena Corporation PLC(PRTA) | EQUITIES | G72800108 | $4.3M | 71,706 | 1.2% |
| Merus NV | EQUITIES | N5749R100 | $4.2M | 274,704 | 1.2% |
| Pliant Therapeutics Inc(PLRX) | EQUITIES | 729139105 | $4.2M | 217,503 | 1.2% |
| MacroGenics Inc(MGNX) | EQUITIES | 556099109 | $4.1M | 612,475 | 1.2% |
| Allakos Inc(ALLKGUSD) | EQUITIES | 01671P100 | $4.0M | 480,701 | 1.2% |
| Vaxcyte Inc(PCVX) | EQUITIES | 92243G108 | $4.0M | 83,135 | 1.1% |
| Immatics Nv(IMTX) | EQUITIES | N44445109 | $3.8M | 439,788 | 1.1% |
| Vertex Pharmaceuticals Inc(VRTX) | EQUITIES | 92532F100 | $3.3M | 11,384 | 0.9% |
| BioCryst Pharmaceuticals Inc(BCRX) | EQUITIES | 09058V103 | $3.1M | 272,173 | 0.9% |
| Point Biopharma Global Inc | EQUITIES | 730541109 | $2.9M | 400,812 | 0.8% |
| Avidity Biosciences Inc(RNA) | EQUITIES | 05370A108 | $2.8M | 128,000 | 0.8% |
| Ascendis Pharma A/S(ASND) | EQUITIES | 04351P101 | $2.8M | 23,151 | 0.8% |
| Crinetics Pharmaceuticals Inc(CRNX) | EQUITIES | 22663K107 | $2.8M | 152,747 | 0.8% |
| Phreesia Inc(PHR) | EQUITIES | 71944F106 | $2.8M | 85,390 | 0.8% |
| Altimmune, Inc.(ALT)Call | LONG OPTION CALLS | 02155H200 | $2.6M | 160,000 | 0.8% |
| Horizon Therapeutics Plc | EQUITIES | G46188101 | $2.6M | 23,054 | 0.8% |
| Insmed Inc(INSM) | EQUITIES | 457669307 | $2.5M | 124,465 | 0.7% |
| Celldex Therapeutics Inc(CLDX) | EQUITIES | 15117B202 | $2.4M | 54,699 | 0.7% |
| Cullinan Oncology Inc(CGEM) | EQUITIES | 230031106 | $2.4M | 229,416 | 0.7% |